SCHEMBL18704

SCHEMBL18704

Cc1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2)cc1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.75
MEN1 O00255 3/20 0.75
KMT2A Q03164 3/20 0.75
JAK2 O60674 1/20 0.75
NPC1 O15118 2/20 0.74
RAB9A P51151 1/20 0.74
MAPK1 P28482 1/20 0.74
PKM P14618 2/20 0.69
GCK P35557 1/20 0.64
GCKR Q14397 1/20 0.64
USP2 O75604 1/20 0.60
HTR7 P34969 1/20 0.57
KDM4E B2RXH2 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
HTT P42858 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
GAA P10253 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18886 0.86 MAPT (1.00) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL12089243 0.85 MAPT (0.70) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL12089501 0.84 MAPT (0.72) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL12088871 0.83 GCKR (0.74) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL26672755 0.81 NPC1 (0.64) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL15462062 0.81 MAPT (0.67) MAPTMEN1KMT2AJAK2NPC1
SCHEMBL33152 0.80 GCKR (0.81) MAPTMEN1KMT2AJAK2MAPK1
SCHEMBL15854 0.80 GCKR (0.81) MAPTMEN1KMT2AJAK2MAPK1
SCHEMBL12078733 0.80 GCKR (0.81) MAPTMEN1KMT2AJAK2MAPK1
SCHEMBL1617605 0.79 MAPT (0.69) MAPTMEN1KMT2AJAK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed